• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Benchstrength Closes $62M Early-Stage VC Fund with Healthcare Focus

by Fred Pennic 12/18/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Benchstrength, a New York City-based venture capital firm, has announced the close of its first $62M fund, focused on investing in high-potential, early-stage technology companies. 

– The $62M fund has attracted a diverse group of investors, including prominent foundations, institutional investors, and individual investors.

Investing in Transformative Technologies

Led by former General Catalyst investors Ken Chenault Jr. and John Monagle, Benchstrength seeks to invest in pre-seed and seed-stage companies across various sectors, including enterprise, consumer, fintech, and healthcare. The firm’s mission is to support companies that not only transform businesses but also uplift communities.

Diverse Portfolio Companies

Benchstrength’s portfolio already includes 20 companies across multiple sectors, showcasing its commitment to investing in innovative technologies with the potential for significant impact. Some of its portfolio companies include:

  • Altis Labs: An AI-powered software company that helps pharmaceutical companies run more efficient clinical trials.
  • Alta: An AI-based personal stylist and shopping platform.
  • Cashmere: AI-powered software that helps wealth management firms acquire more clients.
  • Systole Health: A women’s healthcare technology company focused on providing group-based cardiometabolic care.

A Focus on Impact and Innovation

Benchstrength’s mission extends beyond financial returns. The firm seeks to invest in companies that are not only commercially successful but also contribute to positive social impact and uplift communities. This commitment to both financial and social returns sets Benchstrength apart in the venture capital landscape.

“The venture industry comes down to networks, which leave many founders out,” said Ken Chenault Jr., Co-Founder and Managing Partner at Benchstrength. “We believe significant alpha exists in backing and supporting founders who have been historically overlooked by the industry. At Benchstrength, we are focused on backing world-class founders who are building transformative technology companies. By supporting founders from all backgrounds, we can help fuel entrepreneurial flywheels of the future that will help create the next class of iconic companies.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Healthcare Venture Capital

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

Aligning IT & Clinical Teams: How to Reduce Friction and Improve Communication

Most-Read

Why Brain Health Is Entering Its Infrastructure Era

Brain Health’s Infrastructure Era: Proving Clinical Outcomes with Integrated Neuromotor Tracking

Why Catholic Health Inked a $500M Care Alliance with GE HealthCare to Automate Outpatient Triage

Catholic Health Inks $500M Care Alliance with GE HealthCare to Automate Outpatient Triage

KLAS Global HIT Trends 2026 Report: Artificial Intelligence Becomes the Top Investment Priority

KLAS Global HIT Trends 2026 Report: Artificial Intelligence Becomes the Top Investment Priority

Optum Partners with Anthropic to Deploy Claude Across Healthcare Claims and Revenue Workflows

Optum Partners with Anthropic to Deploy Claude Across Healthcare Claims and Revenue Workflows

Rock Health H1 2026 Digital Health Funding Recap: Startups Hit $7.4B in Venture Rebound

Rock Health H1 2026 Digital Health Funding Recap: Startups Hit $7.4B in Venture Rebound

M&A: ResMed to Sell MatrixCare Business to Frazier Healthcare Partners for $450M

M&A: ResMed to Sell MatrixCare Business to Frazier Healthcare Partners for $450M

The Real Risk in Healthcare AI Isn’t the Model. It’s the Data. 

Clinical Data Fidelity: The Real Blindspot in Healthcare AI Strategy

KLAS 2026 EHR Market Share Report: Epic Gains as Oracle Health Faces Third Year of Losses

KLAS 2026 EHR Market Share Report: Epic Gains as Oracle Health Faces Third Year of Losses

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

M&A: Qualtrics Completes $6.75B Acquisition of Press Ganey Forsta

Viz.ai Launches Viz Pulmonary™ Suite: AI-Powered Workflows for COPD, Lung Nodules, and PE

Viz.ai Launches Viz Pulmonary™ Suite: AI-Powered Workflows for COPD, Lung Nodules, and PE

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |